Judith Sirokay

438 total citations
9 papers, 164 citations indexed

About

Judith Sirokay is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Judith Sirokay has authored 9 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Judith Sirokay's work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Virus-based gene therapy research (2 papers). Judith Sirokay is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Virus-based gene therapy research (2 papers). Judith Sirokay collaborates with scholars based in Germany, Switzerland and Australia. Judith Sirokay's co-authors include Jennifer Landsberg, Anne Fröhlich, Dennis Niebel, Friederike Hoffmann, Romina Zarbl, Dimo Dietrich, Glen Kristiansen, Jörn Dietrich, Gerrit H. Gielen and Thomas Bieber and has published in prestigious journals such as Radiology, Clinical Chemistry and Frontiers in Oncology.

In The Last Decade

Judith Sirokay

9 papers receiving 164 citations

Peers

Judith Sirokay

ONCOL

MB

IMMUN

EPIDE

CCM

Varina R. Clark United States

Raffael Thaler Germany

Antonino Romanzo Italy

Takashi Mineo Japan

Patric Teodorescu Romania

Igor Bartenjev Slovenia

F. Brunet‐Possenti France

Victoire Cardot‐Ruffino United States

Alessandra Tesser Italy

Sven Eisold Germany

Varina R. Clark United States

Judith Sirokay

249 ×3.0

ONCOL

91 ×1.3

MB

102 ×2.0

IMMUN

41 ×1.6

EPIDE

16 ×0.6

CCM

Citations per year, relative to Judith Sirokay Judith Sirokay (= 1×) peers Varina R. Clark

Countries citing papers authored by Judith Sirokay

Since Specialization

Citations

This map shows the geographic impact of Judith Sirokay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Sirokay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Sirokay more than expected).

Fields of papers citing papers by Judith Sirokay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Sirokay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Sirokay. The network helps show where Judith Sirokay may publish in the future.

Co-authorship network of co-authors of Judith Sirokay

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Sirokay. A scholar is included among the top collaborators of Judith Sirokay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Sirokay. Judith Sirokay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Waha, Andreas, Gerrit H. Gielen, Motaz Hamed, et al.. (2024). Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug Screening. Pharmaceutics. 16(8). 1042–1042. 2 indexed citations

2.

Vos, Luka de, Romina Zarbl, Judith Sirokay, et al.. (2024). Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma. Clinical Chemistry. 70(3). 516–527. 3 indexed citations

3.

Faron, Anton, Alexander Isaak, Narine Mesropyan, et al.. (2021). Cardiac MRI Depicts Immune Checkpoint Inhibitor–induced Myocarditis: A Prospective Study. Radiology. 301(3). 602–609. 39 indexed citations

4.

Vos, Luka de, Anne Fröhlich, Christine Braegelmann, et al.. (2021). Grzybowski’s Generalized Eruptive Keratoacanthomas in a Patient with Terminal Kidney Disease—An Unmet Medical Need Equally Ameliorated by Topical Imiquimod Cream and Lapacho Tea Wraps: A Case Report. Dermatology and Therapy. 11(2). 625–638. 3 indexed citations

5.

Fröhlich, Anne, et al.. (2020). Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB–IV M1c melanoma patients. Cancer Immunology Immunotherapy. 69(5). 759–769. 22 indexed citations

6.

Niebel, Dennis, Judith Sirokay, Friederike Hoffmann, et al.. (2020). Clinical Management of Locally Advanced Basal-Cell Carcinomas and Future Therapeutic Directions. Dermatology and Therapy. 10(4). 835–846. 17 indexed citations

7.

Fröhlich, Anne, Emma Bawden, Jörn Dietrich, et al.. (2020). Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma. EBioMedicine. 52. 102647–102647. 43 indexed citations

8.

Hoffmann, Friederike, Romina Zarbl, Dennis Niebel, et al.. (2020). Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma. Clinical Epigenetics. 12(1). 94–94. 28 indexed citations

9.

Fröhlich, Anne, Friederike Hoffmann, Dennis Niebel, et al.. (2020). Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case Report. Frontiers in Oncology. 10. 611–611. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact